Cited by 145Berberine and alkaloids researchGut microbiota and healthPharmacology and Obesity Treatment

The effect of Berberine on weight loss in order to prevent obesity: A systematic review

Open access
Ilyas, Zahra, Perna, Simone, Al-thawadi, Salwa, Alalwan, Tariq A., Riva, Antonella, Petrangolini, Giovanna, Gasparri, Clara, Infantino, Vittoria +2 more·2020·Biomedicine & Pharmacotherapy

Abstract

This study provides a critical overview of experimental studies in vitro, in humans, and in animals that evaluated the efficacy of Berberine and its effect on management of obesity and the related metabolic consequences. As a result of this review, we summarized the effects of Berberine in different models and the related mechanism of actions. In preclinical models, Berberine demonstrates that it affects gut microbiota by reducing diversity of microbes starting at a dosage of 100 mg/kg/day. Moreover, in animal models, Berberine explicates an action on glucose through the inhibition of α-glycosidase at a dose of 200 mh/kg/day. Berberine is also known to be effective against differentiation of adipocytes through a decrease in LXRs, PPARs, and SREBPs expression at 150 mg/kg/day. Other mechanism ascribed to Berberine are related to its inhibition of hepatic gluconeogenesis through the Phospheoenolpyruvate carboxykinase (PEPCK), Glucose-6-phosphate (G6Pase) and AMP-activated protein kinase (AMPK). Furthermore, Berberine (associated to Red Yeast Rice) is effective in decreasing lipid levels in rats, which consequently lowers the change of weight gain at dosage of 40 mg/kg to 380 mg/kg/day. All the above preclinical data are confirmed in human studies where Berberine can modulate the diversity of gut microbes at the dose of 500 mg/day. In addition, Berberine is found to have a beneficial impact on gene regulation for the absorption of cholesterol at a daily dose of 300 mg in humans, an amelioration on glucose accumulation at 1.0 g daily dose was also observed. For all these reasons, this review gives an important good account of the impact of Berberine in obesity treatment and prevention.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2020.110137

Cites

49 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ilyas, Z., Perna, S., Al-thawadi, S., Alalwan, T. A., Riva, A., Petrangolini, G., Gasparri, C., Infantino, V., Peroni, G., & Rondanelli, M.
Affiliations
  • University of Bahrain (BH)
  • Indena (Italy) (IT)
  • University of Pavia (IT)
Corresponding author
Gasparri, Clara
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2020-07
Volume
127
Pages
110137
ISSN
0753-3322 (ISSN-L)
OpenAlex
W3017967363
Cited by
143
References
51
Citations by year
2026: 24 · 2025: 33 · 2024: 22 · 2023: 18 · 2022: 21 · 2021: 21 · 2020: 4
FWCI
2.13
Type
journal article
Language
en
Open access
Locations
  • Biomedicine & Pharmacotherapy (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Pharmacology › Berberine and alkaloids research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
Keywords
berberine, obesity prevention, weight loss, gut microbiota, α-glucosidase inhibition, adipogenesis, liver X receptor, peroxisome proliferator-activated receptors, SREBP, hepatic gluconeogenesis, phosphoenolpyruvate carboxykinase, AMPK, red yeast rice, lipid lowering, cholesterol absorption, glucose metabolism
MeSH terms
Gastrointestinal Microbiome, Berberine, Blood Glucose, Cholesterol, Gluconeogenesis, Humans, Insulin Resistance, Obesity, Weight Loss, Adipocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review